{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-044125","form_type":"8-K","ticker":"QUCY","cik":"0001874252","company_name":"Quantum Cyber N.V.","filed_at":"2026-04-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.207506+00:00","generated_at":"2026-05-15T06:10:32.975996+00:00","sec_items":["1.01","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Mainz Biomed sells next-gen CRC screening IP for $1.25M, updates Nasdaq equity compliance","bullets":["Entered asset purchase agreement to sell Next Gen IP for $1.25M; closing by April 23, 2026.","Proceeds to be used for settlement of outstanding liabilities and general corporate purposes.","Continues development of pancreatic cancer detection product and explores post-quantum cybersecurity.","Believes stockholders' equity exceeds $2.5M after receiving $6M total from preferred share sale (Feb & March 2026).","Previously wound down ColoAlert product and next-gen colorectal cancer screening development in Feb 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-044125","json":"https://secwatch.observer/filing/0001213900-26-044125.json","markdown":"https://secwatch.observer/filing/0001213900-26-044125.md","text":"https://secwatch.observer/filing/0001213900-26-044125.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1874252/000121390026044125/0001213900-26-044125-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1874252/000121390026044125/ea0286510-8k_mainz.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T06:10:32.975996+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a51490c0907e820a82169c0a8c681884486c892c","claim":"Quantum Cyber N.V. entered into Agreement with third-party purchaser incorporated in Italy valued at $1.25 million (effective 2026-04-09).","evidence_excerpt":"On April 9, 2026, we entered into an asset purchase agreement (the “Agreement”) for the sale of the Next Gen IP to a third-party purchaser incorporated in Italy. Pursuant to the Agreement, we will sell the Next Gen IP to the buyer for a payment of $1.25 million.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1874252/000121390026044125/0001213900-26-044125-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"third-party purchaser incorporated in Italy"},{"label":"Value","value":"$1.25 million"},{"label":"Effective","value":"2026-04-09"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}